Are you Dr. Chui?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 63 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3181 Sw Sam Jackson Park Rd
Mail Code L586, Mnp 3208
Portland, OR 97239Phone+1 503-494-6594- Is this information wrong?
Summary
- Dr. Stephen Chui, MD is an oncologist in Portland, Oregon. He is currently licensed to practice medicine in Oregon. He is affiliated with OHSU Hospital and Portland HCS.
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 2001 - 2004
- Duke University HospitalResidency, Internal Medicine, 1996 - 1999
- Duke University School of MedicineClass of 1996
Certifications & Licensure
- OR State Medical License 2006 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Start of enrollment: 2010 Mar 01
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy Start of enrollment: 2011 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 692 citationsAtezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficac...Peter Schmid, Hope S. Rugo, Sylvia Adams, Andreas Schneeweiss, Carlos H. Barrios
The Lancet. Oncology. 2020-01-01 - 66 citationsIntratumor mapping of intracellular water lifetime: metabolic images of breast cancer?Charles S. Springer, Xin Li, Luminita A. Tudorica, Karen Y. Oh, Nicole Roy
NMR in Biomedicine. 2014-07-01 - 515 citationsNeoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stag...Elizabeth A. Mittendorf, Hong Zhang, Carlos H. Barrios, Shigehira Saji, Kyung Hae Jung
Lancet. 2020-10-10
Press Mentions
- Panel Tells FDA to Keep Atezolizumab Approval in TNBCApril 28th, 2021
- FDA Panel Questions Roche's Tecentriq-Abraxane Combo in Breast Cancer, but Votes to Keep Approval in Place for NowApril 27th, 2021
Hospital Affiliations
- Portland HCSPortland, Oregon
- OHSU HospitalPortland, Oregon